The global ambulatory surgical equipment market is valued at USD 7.39 billion in 2026 and is expected to reach USD 14.58 billion by 2035, growing at a 7.85% CAGR. North America dominates with 34% market share, while Asia Pacific is the fastest-growing region. Endoscopy and laparoscopy systems lead by product type at 18% share, with compact intraoperative imaging expected to grow fastest. Independent ambulatory surgical centers account for 42% of the market.

The global surgical stapling devices market was valued at USD 5.47 billion in 2025 and is projected to reach USD 10.14 billion by 2035, growing at a 7.2% CAGR. Growth is driven by increasing surgical volumes, adoption of minimally invasive and robotic procedures, rising obesity and colorectal disease prevalence, and technological innovations in powered stapling systems. North America leads the market while Asia Pacific shows the fastest growth.

Smith+Nephew announced it will showcase advanced orthopaedic technologies at AAOS 2026, including its CORI handheld robotic surgical system for hip, knee and shoulder arthroplasty, new trauma solutions like the EVOS plating system, and an expanded ASC portfolio. The company also announced distribution agreements with SI-BONE for pelvic fracture solutions and RMR Ortho for nitinol fixation technology.

Smith+Nephew will showcase its rotator cuff repair portfolio at AAOS 2026, featuring the newly acquired Tendon Seam Repair System and REGENETEN Bioinductive Implant. The company also announced exclusive US distribution agreements with RMR Ortho for A'TOMIC nitinol fixation technology and SI-BONE for their iFuse TORQ portfolio, expanding its orthopedic offerings.

The global scar treatment market is projected to grow from USD 26.60 billion in 2025 to USD 56.30 billion by 2033, with a CAGR of 9.91%. Growth is driven by increasing awareness of advanced cosmetic and reconstructive procedures, rising prevalence of acne, surgical, and traumatic scars, and technological advancements in minimally invasive treatments. The U.S. market alone is expected to reach USD 17.69 billion by 2033.

The global anti-biofilm agents market is experiencing robust growth driven by escalating hospital-acquired infections (13% higher than pre-pandemic levels), rising antimicrobial resistance, and increasing prevalence of chronic wounds among the 589 million diabetic population. Key growth drivers include FDA regulatory support, industrial water treatment demand, and hospital adoption of advanced biofilm-disrupting technologies. Dressings and silver-based solutions dominate the market, with North America leading regionally and Asia Pacific showing fastest growth.

The global orthopedic implants market is projected to grow from USD 23.50 billion in 2025 to USD 33.20 billion by 2033, expanding at a CAGR of 4.43%. Growth is driven by rising musculoskeletal disorders, aging populations, technological advancements in biomaterials and minimally invasive procedures, and digital orthopedic solutions. However, high implant costs, strict regulatory requirements, and pricing pressures from healthcare providers remain key challenges.

The global surgical staplers market is projected to grow from USD 6.41 billion in 2025 to USD 10.87 billion by 2033, at a CAGR of 6.87%. Growth is driven by increasing surgical volumes, adoption of minimally invasive procedures, and technological advancements in powered and disposable stapling systems. However, high device costs and stringent regulatory requirements pose challenges to market expansion.

The global advanced wound closure market is projected to grow from USD 18.47 billion in 2025 to USD 32.54 billion by 2035, at a CAGR of 6.9%. Growth is driven by increasing surgical procedures, rising chronic wounds and diabetes cases, and technological innovations in surgical sealants, hemostats, and tissue adhesives. North America leads the market while Asia Pacific shows the highest growth potential.

The global orthopedic implants market is valued at USD 52.86 billion in 2026 and is expected to reach USD 80.14 billion by 2034, growing at a 5.34% CAGR. North America leads the market while Asia-Pacific is the fastest-growing region. Joint reconstruction dominates by product type, with spinal implants showing significant growth potential. Key drivers include an aging population, rising musculoskeletal disorders, and technological innovations in 3D-printed and AI-enabled implants.

The global arthroscopy devices market is projected to grow from USD 8.8 billion in 2024 to USD 11.8 billion by 2032, driven by rising incidence of joint disorders, sports injuries, aging populations, and technological advancements in minimally invasive surgical procedures. North America leads the market, with Asia-Pacific expected to witness the fastest growth.

The global anti-biofilm wound dressing market is projected to grow from USD 863.95 million in 2025 to USD 1.82 billion by 2033, at a CAGR of 9.76%. Growth is driven by increasing antibiotic-resistant infections, rising chronic wound cases, and adoption of advanced antimicrobial wound care solutions. North America leads the market with 38.50% share, while Asia-Pacific is the fastest-growing region.